PICCINNI, CARLO
 Distribuzione geografica
Continente #
NA - Nord America 4.518
AS - Asia 3.661
EU - Europa 3.625
AF - Africa 247
SA - Sud America 237
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 12.298
Nazione #
US - Stati Uniti d'America 4.454
IT - Italia 1.088
VN - Vietnam 972
SG - Singapore 952
CN - Cina 831
GB - Regno Unito 810
DE - Germania 453
HK - Hong Kong 379
SE - Svezia 324
FR - Francia 218
IN - India 184
RU - Federazione Russa 182
BR - Brasile 173
UA - Ucraina 147
IE - Irlanda 112
JP - Giappone 91
ZA - Sudafrica 83
CI - Costa d'Avorio 78
NL - Olanda 68
EE - Estonia 56
FI - Finlandia 45
TG - Togo 42
CA - Canada 40
BD - Bangladesh 38
PH - Filippine 31
BE - Belgio 30
AR - Argentina 29
JO - Giordania 23
TW - Taiwan 22
TH - Thailandia 21
AT - Austria 18
ID - Indonesia 14
KR - Corea 14
MX - Messico 14
CH - Svizzera 13
NG - Nigeria 13
PK - Pakistan 13
SA - Arabia Saudita 11
SC - Seychelles 11
PL - Polonia 10
TR - Turchia 10
UZ - Uzbekistan 10
CO - Colombia 9
HR - Croazia 9
IQ - Iraq 9
EC - Ecuador 8
LB - Libano 8
GR - Grecia 7
LT - Lituania 7
AU - Australia 6
CL - Cile 5
ES - Italia 5
IR - Iran 5
KE - Kenya 5
PY - Paraguay 5
BG - Bulgaria 4
CZ - Repubblica Ceca 4
MA - Marocco 4
MY - Malesia 4
SK - Slovacchia (Repubblica Slovacca) 4
SY - Repubblica araba siriana 4
CR - Costa Rica 3
EG - Egitto 3
JM - Giamaica 3
NP - Nepal 3
PE - Perù 3
RO - Romania 3
TN - Tunisia 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
DK - Danimarca 2
LY - Libia 2
VE - Venezuela 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
DZ - Algeria 1
EU - Europa 1
IL - Israele 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LV - Lettonia 1
MT - Malta 1
MV - Maldive 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SO - Somalia 1
TT - Trinidad e Tobago 1
UG - Uganda 1
VG - Isole Vergini Britanniche 1
Totale 12.298
Città #
Southend 701
Singapore 597
Ashburn 390
Chandler 361
Hong Kong 348
Fairfield 338
Santa Clara 320
San Jose 252
Ho Chi Minh City 234
Dong Ket 199
Wilmington 197
Princeton 193
Hanoi 155
Ann Arbor 150
Houston 149
Woodbridge 147
Beijing 117
Seattle 116
Dublin 107
Boardman 106
Cambridge 98
Los Angeles 98
Bologna 94
Dallas 87
Jacksonville 86
Lauterbourg 85
Rome 80
Abidjan 78
Nanjing 78
Westminster 78
Padova 75
Tokyo 66
Milan 50
Medford 49
Shenyang 43
Buffalo 42
Helsinki 42
Lomé 42
Saint Petersburg 39
Berlin 35
Bremen 34
Dearborn 34
New York 34
Mülheim 33
Brussels 28
Changsha 27
Nanchang 27
Da Nang 26
Frankfurt am Main 26
Jinan 26
Redwood City 26
Amman 23
Olalla 23
San Diego 23
Council Bluffs 22
Redondo Beach 22
Guangzhou 21
Hebei 21
San Venanzo 21
Hefei 20
Palermo 20
Shanghai 20
Turin 20
Florence 19
São Paulo 19
The Dalles 19
Munich 17
Tianjin 17
Zhengzhou 17
Bari 16
Haiphong 16
Falls Church 15
Hangzhou 15
London 15
Phoenix 15
Haikou 14
Taipei 14
Abeokuta 13
Bangkok 12
Chicago 12
Kunming 12
Norwalk 12
Toronto 12
Biella 11
Biên Hòa 11
Jiaxing 11
Ningbo 11
Orem 11
Yubileyny 11
Lanzhou 10
Messina 10
Naples 10
Hải Dương 9
Montreal 9
Redmond 9
Torino 9
Trieste 9
Brooklyn 8
Bühl 8
Cagliari 8
Totale 7.565
Nome #
Leucoencefalopatia Multifocale Progressiva: complicanza dell'immunosoppressione o reazione avversa da farmaci? 605
Data Mining Techniques in Pharmacovigilance: Analysis of the Publicly Accessible FDA Adverse Event Reporting System (AERS) 303
Farmacoutilizzazione in ospedale: analisi delle variabilità in una realtà regionale 291
Adverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: Systematic review of observational studies 272
Appropriateness of Proton Pump Inhibitor (PPI) prescription in patients admitted to hospital: Attitudes of general practitioners and hospital physicians in Italy 262
Switching among Equivalents in Chronic Cardiovascular Therapies: 'Real World' Data from Italy 247
Emilia-Romagna Study on Pregnancy and Exposure to Antiepileptic drugs (ESPEA): a population-based study on prescription patterns, pregnancy outcomes and fetal health 227
Predictors of antipsychotic prescription in a Northern Italian District (Bologna) 218
Long-acting injectable antipsychotics: Six-month follow-up of new outpatient treatments in Bologna Community Mental Health Centres 207
Association between Paraesthesia and Local Anesthetics: Data Mining of the Public Version of the FDA Adverse Event Reporting System, 204
Use of phytoestrogens and effects perceived by postmenopausal women: result of a questionnaire-based survey 199
Social and clinical descriptors of antipsychotic prescription 196
Cardiovascular, Ocular and Bone Adverse Reactions Associated with Thiazolidinediones: A Disproportionality Analysis of the US FDA Adverse Event Reporting System Database. 192
Triptans and serious adverse vascular events: Data mining of the FDA Adverse Event Reporting System database 192
A real-world study on unmet medical needs in triptan-treated migraine: Prevalence, preventive therapies and triptan use modification from a large Italian population along two years 192
Prescription patterns of antiepileptic drugs in young women: development of a tool to distinguish between epilepsy and psychiatric disorders 190
Determinanti demografici, clinici ed organizzativi dell'aderenza alla poli-terapia dopo infarto miocardico acuto 189
Stronger association of drug-induced progressive multifocal leukoencephalopathy (PML) with biological immunomodulating agents. 188
Cardiovascular events in statin recipients: impact of adherence to treatment in a 3-year record linkage study 185
Clinically important drug-drug interactions in poly-treated elderly outpatients: A campaign to improve appropriateness in general practice 185
Disproportionality signal of progressive multifocal leukoencephalopathy: monoclonal antibodies versus other immunosuppressants 182
Assessing the association of pioglitazone use and bladder cancer through drug adverse event reporting 182
Paraesthesia after Local Anaesthetics: An Analysis of Reports to the FDA Adverse Event Reporting System 169
Organisational determinants of adherence to secondary prevention medications after acute myocardial infarction 167
La condivisione dei trattamenti farmacologici in psichiatria e la percezione degli effetti avversi ai farmaci antipisicotici da medico, paziente e familiare 163
Predictors of non-adherence with oral bisphosphonates: an Italian retrospective cohort study on administrative databases 162
Fattori determinanti nell'utilizzo dei farmaci antipsicotici 158
Use and Perception of Phytoestrogens in Postmenopausal Women: Result of a Questionnaire-Based Survey 157
Triptans and serious cardiovascular events: possible safety signals from the FDA Adverse Event Reporting System database 155
Profili di utilizzo dei farmaci antipsicotici nei centri salute mentale della AUSL di Bologna: determinanti clinici e sociali 155
Determinanti demografici, clinici ed organizzativi dell’aderenza alla poli-terapia dopo infarto miocardico acuto 155
Aderenza al trattamento con Bifosfonati: studio di coorte retrospettivo su database amministrativi dell’Emilia Romagna 154
Phytoestrogens in postmenopause: the state of the art from a chemical, pharmacological and regulatory perspective 152
The association of pancreatitis with antidiabetic drug use: gaining insight through the FDA pharmacovigilance database. 150
Infarto del miocardio, edema maculare e fratture associate ai glitazoni: analisi del database di segnalazione spontanea FDA_AERS 149
Risk of atrial fibrillation among bisphosphonate users: a multicenter, population-based, Italian study 148
Progressive Multifocal Leukoencephalopathy: an effect of immunodeficiency or an adverse drug reaction? 146
Pioglitazone-associated bladder cancer: the contribution of spontaneous reporting analysis on the basis of FDA_AERS database 145
Prescription patterns of oral bisphosphonates in Italian patients with osteoporosis 145
Cardiovascular events in statin recipients: a 3-year record-linkage study on prescription and hospital discharge databases 143
La rimborsabilità di memantina - il trilemma di Münchausen 142
Impact of notoriety bias on reporting of pancreatitis with antidiabetics: the case of exenatide 142
Safety profile of thiazolidinediones on the basis of the FDA-AERS database: cardiovascular and bone fracture risks for rosiglitazone and pioglitazone 142
Analyses of natalizumab prescriptions and discontinuations in multiple sclerosis patients of an Italian region 139
Risk-management of natalizumab: a drug utilization study on duration of therapy and cause of discontinuation in Emilia-Romagna region 139
Trends in antiarrhythmic drug use after marketing authorization of dronedarone: comparison between Emilia Romagna (Italy) and Sweden. 137
Progetto europeo di confronto dell'uso dei farmaci 136
Assessing the risk of Osteonecrosis of the Jaw (ONJ) due to bisphosphonates (BP) therapy in the secondary prevention of osteoporotic fractures 134
Aderenza alla terapia antidepressiva in Emilia-Romagna 130
Progressive Multifocal Leukoencephalopathy (PML): only immunosuppressive complication or also drug adverse reaction? 130
Burden of community-acquired pneumonia in Italian general practice 130
Trend in SSRI-SNRI antidepressants prescription over a 6-year period and predictors of poor adherence 128
A project for monitoring disease modifying drug prescriptions for multiple sclerosis in Emilia Romagna 127
Psychiatrists’ Use of Shared Decision Making in the Treatment of Psychosis: The “Farmaci and Famiglie” Project in Bologna 127
Assessing the risk of Osteonecrosis of the Jaw (ONJ) due to Bisphosphonates (BP) therapy in the secondary prevention of osteoporotic fractures, 124
The key role of patient in the antipsychotic therapy: shared decision making, adherence and research 124
The pharmacovigilance program on natalizumab in Italy: 2 years of experience 122
Natalizumab: a country-based surveillance program 121
Three years of experience: the Italian registry and safety data update 120
Safety profile of antiviral medications: a pharmacovigilance study using the Italian spontaneous-reporting database. 119
Healthcare of patients with immunoglobulin A nephropathy through a retrospective observational study of Italian administrative data 113
Glucagon-like peptide 1-based drugs and pancreatic safety. 113
Progetto di monitoraggio della prescrizione di farmaci disease-modifying nella sclerosi multipla in Emilia-Romagna 113
I rapporti tra medici, pazienti e familiari nella scelta delle terapie farmacologiche dei disturbi psichici: un’indagine presso il dipartimento di salute mentale della AUSL di Bologna 111
Monitoring the use of disease-modifying drugs in multiple sclerosis 110
The Italian Surveillance Program on Natalizumab 107
Factors Influencing the Disproportional Association Between Triptans and Cerebrovascular Events Within the FDA_AERS Database: Causal Association or Reporting Bias? 104
Lack of adherence to oral bisphosphonates in Italian patients: prevalence and predictors 103
Drug-related Progressive Multifocal Leukoencephalopathy (PML): datamining of FDA_AERS (Adverse Event Reporting System) 103
VII Report Health Search Anno 2011/2012 102
L’uso dei farmaci in Italia. Rapporto nazionale anno 2011 102
Drug-induced Progressive Multifocal Leukoencephalopathy: data mining of international spontaneous ADR report databases 101
Prescrizione di Entacapone nella Regione Emilia-Romagna 99
Interrupted time series analysis on the impact of dronedarone authorisation on Italian and Swedish antiarrhythmic prescriptions 99
Monitoring disease-modifying drugs in multiple sclerosis in Emilia Romagna 98
Insights into real-world treatment of cluster headache through a large Italian database: prevalence, prescription patterns, and costs 98
The Italian Natalizumab Registry: a 1-year follow-up 96
Impact of dronedarone authorisation on antiarrhythmic utilisation: interrupted time series strategy on Italian and Swedish prescription databases 83
Use of disease-modifying drugs for multiple sclerosis in neurological centres of Emilia Romagna 82
Drug utilisation of antidepressants in Generai Practice: choice of drugs and adherence in an Italian region 76
Totale 12.507
Categoria #
all - tutte 31.869
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.869


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021354 0 0 0 0 0 0 0 0 0 0 0 354
2021/20221.466 153 66 69 105 127 93 28 87 45 98 356 239
2022/20231.598 195 199 116 212 88 116 40 108 261 64 142 57
2023/2024563 44 79 38 70 57 50 38 31 25 46 58 27
2024/20251.616 99 239 110 116 421 107 86 48 21 74 32 263
2025/20263.768 194 290 368 188 457 216 622 129 654 356 179 115
Totale 12.507